Trial intelligence / Profile preview

Magnesium Preloading for Cisplatin Nephrotoxicity

NCT02481518Phase 4Completed

Sponsor
Mahidol University
Start
Mar 2015
Primary completion
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of magnesium sulfate in acute kidney injury (AKI) (2 arms), sponsored by Mahidol University. Primary endpoint: Acute Kidney Injury at 7 days. Started Mar 2015; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT02481518.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02481518.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call